Technologie: „Noch nie so dramatisch wie jetzt“: Chinas Fortschritt in Medizintechnik alarmiert deutsche Industrie
Chinesische Hersteller drängen mit Hochtechnologie in den europäischen Markt – und werden in China selbst bevorzugt. Für deutsche Unternehmen wird es schwerer, ihren Vorsprung zu halten.
Shanghai, China - The transparent plastic heart, capable of mimicking a full body's vascular system from the brain to the toes, is causing alarm among Germany's medical technology industry. Wu Bing, a sales manager at Preclinic Medtech, a Chinese company founded in 2017 near Shanghai Jiaotong University, notes that Chinese companies like his are producing artificial vessels, organs, and body parts for medical procedures and testing advanced medical devices.
The Chinese medtech sector has long been significant as both a market and a production hub, particularly for major German manufacturers like Siemens Healthineers and Fresenius Kabi. However, competition among Western companies vying for market share in China is intensifying. A Siemens Healthineers spokesperson acknowledges that Chinese firms have advantages in their home market but emphasizes that they continue to gain market share in their core areas of imaging and precision therapy.
Chinese companies are increasingly recognized for their innovation capabilities, no longer merely seen as cost-effective reproductions of Western technology.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
